Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)
  7. Department of Pathology and Laboratory Medicine (416)
  8. Gastrointestinal Oncology Service (387)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of temsirolimus and perifosine for recurrent or progressive malignant glioma
    Meeting Abstract

    Lassman, A. B.; Kaley, T. J.; Deangelis, L. M.; Hormigo, A.; Mellinghoff, I. K.; Otap, D. D.; Seger, J.; Doyle, L. A.; Ludwig, E.; Lacouture, M. E.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib in target selected patients with recurrent glioblastoma (RTOG 0627)
    Meeting Abstract

    Lassman, A. B.; Wang, M. H.; Gilbert, M. R.; Aldape, K. D.; Beumer, J. J.; Wright, J.; Takebe, N.; Puduvalli, V. K.; Hormigo, A.; Gaur, R.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Preliminary data from a multicenter, phase II, randomized, noncomparative clinical trial of radiation therapy and temozolomide with or without vandetanib in newly-diagnosed glioblastoma
    Meeting Abstract

    Lee, E. Q.; Batchelor, T. T.; Lassman, A. B.; Schiff, D. S.; Kaley, T. J.; Wong, E. T.; Mikkelsen, T.; Purow, B. W.; Drappatz, J.; Norden, A. D.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Bevacizumab in multiply recurrent aggressive meningiomas
    Meeting Abstract

    Nayak, L.; Iwamoto, F. M.; Rudnick, J. D.; Norden, A. D.; Omuro, A.; Kaley, T. J.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Nf1 loss cooperates with P53 loss more efficiently than ink4/arf loss in glioma formation
    Meeting Abstract

    Ozawa, T.; Charles, N. A.; Huse, J. T.; Helmy, K.; Squatrito, M.; Holland, E. C.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Time trends in treatment of anaplastic oligodendroglial tumors
    Meeting Abstract

    Panageas, K. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Comparing the effect of novottf to bevacizumab in recurrent GBM: A post-hoc sub-analysis of the phase III trial data
    Meeting Abstract

    Ram, Z.; Wong, E. T.; Gutin, P. H.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
    Meeting Abstract

    Reiner, A. S.; Panageas, K. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Functional characterization of micrornas in PDGF-driven gliomas
    Meeting Abstract

    Silber, J.; Jacobsen, A.; Ozawa, T.; Harinath, G.; Brennan, C. W.; Holland, E. C.; Sander, C.; Huse, J. T.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save